Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: the Diabetes in Germany (DIG) Study - PubMed (original) (raw)
Comparative Study
Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: the Diabetes in Germany (DIG) Study
C Koehler et al. Horm Metab Res. 2007 Sep.
Abstract
This study investigated the prevalence of the metabolic syndrome (MetS) in a German population with type 2 diabetes (T2DM) using the three definitions for MetS according to WHO 1999, AHA/NHLBI 2005, and IDF 2005 criteria. Four-thousand and twenty participants as a cross section of daily practice of diabetes care in Germany (238 unselected sites) were included in the Diabetes in Germany (DIG) study.
Inclusion criteria: T2DM and age between 35-80 years.
Exclusion criteria: major cardiovascular event < 3 months before entry, NYHA-IV, macroproteinuria, and cancer < 5 years before entry. The components of MetS were measured following a standard protocol for anthropometric and laboratory control. The average diabetes duration was 8.4 years and HbA (1C) 7.0%. The prevalence of MetS by WHO criteria was 26.1%, by AHA/NHLBI 79.3%, and by IDF 82.6%. The degree of agreement (kappa statistic) was kappa = 0.69 between AHA/NHLBI and IDF definitions, but only 0.12 for WHO VS. IDF, and 0.17 for WHO vs. AHA/NHLBI. The frequency of central obesity by WHO was 50.9%, by AHA/NHLBI 72.9%, and by IDF 92.0% and for hypertension 29.3%, 92.6%, and 92.6%, respectively. However, the frequencies of lipid components by the three definitions were in the same range (57.8%, 59.5%, 59.5%). In this representative German sample of patients with type 2 diabetes, the prevalence of MetS was very highly independent of using the IDF or AHA/NHLBI definition. Females were significantly more affected than males. The distinctly lower prevalence delineated from WHO criteria is due to low frequency of central obesity and hypertension as consequence of higher cutoff limits for these components used in the WHO definition.
Similar articles
- Diagnosing metabolic syndrome in type 2 diabetic Turkish patients: comparison of AHA/NHLBI and IDF definitions.
Basol G, Barutcuoglu B, Cakir Y, Ozmen B, Parildar Z, Kose T, Ozmen D, Bayindir O. Basol G, et al. Bratisl Lek Listy. 2011;112(5):253-9. Bratisl Lek Listy. 2011. PMID: 21682078 - Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A; GREECE-METS Collaborative Group. Athyros VG, et al. Int J Cardiol. 2007 Apr 25;117(2):204-10. doi: 10.1016/j.ijcard.2006.04.078. Epub 2006 Jul 18. Int J Cardiol. 2007. PMID: 16854482 - Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study.
Maksimovic MZ, Vlajinac HD, Radak DJ, Marinkovic JM, Jorga JB. Maksimovic MZ, et al. BMC Cardiovasc Disord. 2012 Jan 31;12:2. doi: 10.1186/1471-2261-12-2. BMC Cardiovasc Disord. 2012. PMID: 22292476 Free PMC article. - The criteria for metabolic syndrome and the national health screening and education system in Japan.
Yamagishi K, Iso H. Yamagishi K, et al. Epidemiol Health. 2017 Jan 6;39:e2017003. doi: 10.4178/epih.e2017003. eCollection 2017. Epidemiol Health. 2017. PMID: 28092931 Free PMC article. Review.
Cited by
- Impact of metabolic syndrome on bone mineral density in men over 50 and postmenopausal women according to U.S. survey results.
Tan MY, Zhu SX, Wang GP, Liu ZX. Tan MY, et al. Sci Rep. 2024 Mar 25;14(1):7005. doi: 10.1038/s41598-024-57352-z. Sci Rep. 2024. PMID: 38523143 Free PMC article. - Urine Uric Acid Excretion Levels are Positively Associated with Obesity and Abdominal Obesity in Type 2 Diabetes Patients without Chronic Kidney Disease.
Liu F, Chen S, Zhao W, Chen M, Ke J, Zhang Z, Lu J, Li L. Liu F, et al. Diabetes Metab Syndr Obes. 2021 Dec 1;14:4691-4703. doi: 10.2147/DMSO.S335558. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 34880638 Free PMC article. - Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with Type 2 Diabetes.
Saif-Ali R, Kamaruddin NA, Al-Habori M, Al-Dubai SA, Ngah WZW. Saif-Ali R, et al. Diabetol Metab Syndr. 2020 Aug 5;12:67. doi: 10.1186/s13098-020-00575-7. eCollection 2020. Diabetol Metab Syndr. 2020. PMID: 32774471 Free PMC article. - A Comparison of the Prevalence of the Metabolic Syndrome among Sri Lankan Patients with Type 2 Diabetes Mellitus Using WHO, NCEP-ATP III, and IDF Definitions.
Herath HMM, Weerasinghe NP, Weerarathna TP, Amarathunga A. Herath HMM, et al. Int J Chronic Dis. 2018 Aug 7;2018:7813537. doi: 10.1155/2018/7813537. eCollection 2018. Int J Chronic Dis. 2018. PMID: 30175110 Free PMC article. - Assessment of metabolic syndrome in Kashmiri population with type 2 diabetes employing the standard criteria's given by WHO, NCEPATP III and IDF.
Lone S, Lone K, Khan S, Pampori RA. Lone S, et al. J Epidemiol Glob Health. 2017 Dec;7(4):235-239. doi: 10.1016/j.jegh.2017.07.004. Epub 2017 Aug 9. J Epidemiol Glob Health. 2017. PMID: 29110863 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous